HLA-E and myeloid sarcoma: Furthermore, an in vitro co‐culture experiment showed that the HLA‐E*01:03 allele, in contrast to HLA‐E*01:01, enhances immune control over EBV‐infected B cells through potent HLA‐E‐restricted CD8+ T cell responses, potentially preventing MS‐related autoimmune processes.